Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!
|
|
- Kathleen Flynn
- 6 years ago
- Views:
Transcription
1 Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!
2 DECLARATION No relevant conflicts of interest to declare
3 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
4 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
5 THE BURDEN OF TB Every year, about 9 million develop active TB and 1.4 million die 99% of all TB sufferers live in developing countries Between 2000 and 2020, nearly 1 billion additional people will be newly infected, 200 million will become sick and 35 million will die Globally, the economic costs of TB to the poor are estimated to be US$12 billion per year
6 GLOBAL TB INCIDENCE (2010)
7
8 HIV CO-INFECTION IN NEW TB CASES (2010)
9 THE BURDEN OF PAEDIATRIC TB 1 million clinical cases (11%) occur annually in children, many more infections childhood deaths each year Children who develop disease tend to do so in first two years after exposure to open adult case
10 THE BURDEN OF PAEDIATRIC TB Risk of developing disease after infection with Mycobacterium tuberculosis increases with younger age 5 to 10% 15% 24% 43% adults adolescents children 1 to 5 years of age infants < 1 year of age Risk of progression to TB disease = 10% per year in HIV-positive adults (possibly even higher in HIV-positive children)
11 THE BURDEN OF PAEDIATRIC TB Most common age at presentation is 1 to 4 years Children usually develop Primary TB Some may develop post-primary TB Reactivation Re-infection Relative contributions determined by baseline prevalence
12 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
13 DIFFERENCES BETWEEN CHILDHOOD AND ADULT TB Children have paucibacilliary disease Cavitation is rare in children: only 6% of cases Extrapulmonary TB more often occurs in children Disseminated disease occurs especially in children <3 years of age Children develop fewer anti-tb drug side effects
14 INTRA-THORACIC TB IN CHILDREN
15 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
16 DIAGNOSIS OF TB IN CHILDREN: HISTORY BUT, many cases of Smear positive household contact, often unrecognised confirmed paediatric Symptoms TB will have none of Cough: unremitting, > 21 days Fever: > 38 C for 14 days Weight loss or failure to thrive: RTHC Fatigue Very unlikely if none of: Poor weight gain, current cough or fever these!!
17 DIAGNOSIS OF TB IN CHILDREN Physical signs strongly suggestive of Extrapulmonary TB: Gibbus virtually pathognomonic for spinal TB Non-painful cervical adenopathy with fistula formation
18 DIAGNOSIS OF TB IN CHILDREN Clinical features requiring further investigation: Meningitis not responding to appropriate antibiotic therapy Pleural effusion Non-painful enlarged nodes without fistula formation Pericardial effusion Ascites Non-painful enlarged joint Hypersensitivity phenomena e.g. Erythema nodosum, phlyctenular conjunctivitis
19 DIAGNOSIS OF TB IN CHILDREN: TUBERCULIN SKIN TEST Positive test suggests infection with M. tuberculosis, not necessarily TB disease Mantoux method: 2 new tuberculin units (TU) of PPD-S Equivalent to 5 old TU High-risk children: HIV-infected Severely malnourished 5 mm Other children (irrespective of BCG): 10mm
20 DIAGNOSIS OF TB IN CHILDREN: FALSE NEGATIVE TST Incorrect technique Expired PPD Viral infections: measles, varicella Live viral vaccine within 6 previous weeks Malnutrition Bacterial infections: pertussis, typhoid Immunosuppressive therapy Neonatal patient Primary immunodeficiencies Diseases of lymphoid tissues Low protein states Severe/disseminated TB
21 DIAGNOSIS OF TB IN CHILDREN: FALSE POSITIVE TST Incorrect interpretation of test BCG vaccination Non-tuberculous mycobacterial infection Incorrect technique
22 DIAGNOSIS OF TB IN CHILDREN: MICROBIOLOGICAL Microbiological examination for AFBs: Sputum Gastric aspirates Body fluids Mycobacterial culture: Suspected drug-resistant TB HIV infection Complicated or severe disease Uncertain diagnosis Histological or cytological evidence of TB in extrapulmonary sites
23 DIAGNOSIS OF TB IN CHILDREN: RESPIRATORY TRACT SPECIMENS Expectoration Gastric aspiration Difficult to obtain in children < 5 years old Bacterial yields higher in older children 2 sputum specimens, previously 3 Children unwilling or unable to expectorate 3 consecutive morning samples Sputum induction Bacterial yields better than that of gastric aspirates Slow uptake, but requires no new skills
24 SPUTUM INDUCTION Low-risk procedure Contraindications Procedure Coughing, mild wheezing, nose-bleeds Attention to Infection Control Fasting <3 hours Severe respiratory distress Intubated Bleeding Reduced level of consciousness Significant asthma Administer nebulised bronchodilator Administer hypertonic (3%) saline for 15 minutes or 5 mls Chest physiotherapy (if necessary) Expectorate or suction nose/nasopharynx
25 DIAGNOSIS OF TB IN CHILDREN: SUSPECTED PULMONARY TB Good quality CXR Persistent opacification in the lung (>6 weeks) Enlarged hilar lymph nodes Miliary pattern is useful in HIV-uninfected children Cavitation Pleural effusion CXR notoriously unreliable, especially with HIV
26 INTERFERON-γ RELEASE ASSAYS Immune-based tests for TB infection, not currently disease 2 commercially- available: T-Spot.TB (ELISPOT) Quantiferon-TB Gold In-tube (ELISA) Both measure response to ESAT-6 and CFP-10 Not affected by prior BCG exposure and many environmental mycobacteria High risk of indeterminate results in HIV-positive children Require only 1 clinical visit No boosting effect Expensive Exact role in diagnosing paediatric TB not entirely clear, but not recommended in our setting
27 DIAGNOSIS OF TB IN CHILDREN: OTHER TESTS Interferon-γ Release Assays Serology not recommended Nucleic Acid amplification Antigen-based tests e.g. lipoarabinomannan Newer culture techniques Phage-based tests New skin tests Require further research HIV testing is recommended in all patients in whom TB has been diagnosed HIV PCR HIV ELISA Work up for ART if HIV-infected
28 GENE XPERT
29 DEVELOPMENT PIPELINE FOR NEW DIAGNOSTICS
30 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
31 CATEGORIZING TB INFECTIONS IN CHILDREN: CASE DEFINITIONS Site of disease Result of microbiological investigations Severity of disease History of previous TB treatment Register each case with the National TB Programme when suspected
32 CATEGORIZING TB INFECTIONS IN CHILDREN: PULMONARY TB, SPUTUM SMEAR-POSITIVE 2 initial sputum smears positive for AFBs 1 sputum smear positive for AFB plus CXR consistent with TB OR OR 1 sputum smear positive for AFBs plus culture positive for M. tuberculosis
33 CATEGORIZING TB INFECTIONS IN CHILDREN: PULMONARY TB, SPUTUM SMEAR-NEGATIVE Cases that do not meet the criteria for smear-positive disease, including those with no smear results: At least 3 sputum specimens negative for AFBs AND Radiological changes consistent with pulmonary TB AND No response to broad spectrum antibiotics AND Decision by clinician to treat with a full course of anti-tb therapy
34 CATEGORIZING TB INFECTIONS IN CHILDREN: EXTRAPULMONARY TB Children with only extrapulmonary TB, and no pulmonary involvement If the case has concomitant pulmonary disease, it should be classified as a Pulmonary TB case
35 CATEGORIZING TB INFECTIONS IN CHILDREN: DRUG-RESISTANT TB Suspect drug resistance if: Source Case Known to have drug-resistant TB Sputum smear positive after 3 months of Rx History of previously treated TB History of Treatment interruption Child Contact with a known drug-resistant TB case Not responding to anti-tb treatment regimen Recurrence of TB after adherence on treatment
36 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
37 ANTI-TB THERAPY: OBJECTIVES OF TREATMENT Rapidly kill bacilli (bactericidal) Effect cure and prevent relapse (sterilizing) Prevent progression of disease Prevent transmission of infection Elimination of dormant bacilli Minimal side effects Prevent drug resistance Combination of anti-tb drugs
38 RECOMMENDED REGIMENS Intensive Phase Continuation Phase Rapidly eliminate organisms Prevent emergence of drug resistance Eradicate dormant organisms Drug (WHO 2010) Dose and Range (mg/kg body weight) Isoniazid H Rifampicin R Pyrazinamide Z Ethambutol E Streptomycin S Not Recommended Maximum daily dose (mg)
39 PAEDIATRIC TREATMENT REGIMENS Regimen 3A: 2HRZ, 4HR New smear negative PTB with minimal parenchymal involvement Less severe forms of extra pulmonary TB Regimen 3B: 2HRZE, 4HR TB meningitis: 2RHZEth, 7RHEth Younger than 8 years or weigh less than 30kg Complicated forms of TB: New smear positive PTB Smear negative PTB with extensive parenchymal involvement Severe forms of EPTB SASPID and 2012 SAMF: HIV-infected children Not entirely consistent with other guidelines Reflects consensus opinion & lack of high quality evidence rather than a superior regimen
40 REGIMEN 3A Body weight kg Intensive Phase (2 months) Treatment given 7 days a week RHZ* 60,30,150 Additional isoniazid (5 mg/kg to make total RHZ* 60,60,150 isoniazid dose to mg/kg) Isoniazid 100 mg tablet kg ½ tablet ¼ tablet ½ tablet kg 1 tablet ¼ tablet 1 tablet kg 1½ tablets ½ tablet OR 1½ tablets kg 2 tablets ½ tablet 2 tablets kg 2½ tablets 1 tablet 2½ tablets kg 3 tablets 1 tablet 3 tablets kg 4 tablets 1 ½ tablet 4 tablets kg 5 tablets 1 ½ tablet 5 tablets kg 6 tablets 1 tablet 6 tablets kg 7 tablets 7 tablets
41 REGIMEN 3A Body weight kg Continuation phase (4 months) Treatment given 7 days a week RH 60,30 Additional isoniazid (5 mg/kg to make total RH 60,60 isoniazid dose to mg/kg) Isoniazid 100 mg tablet kg ½ tablet ¼ tablet ½ tablet kg 1 tablet ¼ tablet 1 tablet kg 1½ tablet ½ tablet OR 1½ tablets kg 2 tablets ½ tablet 2 tablets kg 2½ tablets 1 tablet 2½ tablets kg 3 tablets 1 tablet 3 tablets kg 4 tablets 1 ½ tablet 4 tablets kg 5 tablets 1 ½ tablet 5 tablets kg 6 tablets 1 tablet 6 tablets kg 7 tablets 7 tablets
42 REGIMEN 3B NOT CONSISTENT WITH 3A?? Body weight (kg) Intensive Phase (2 months) Directly Observed Treatment (DOT) given 7 days a week Continuation Phase (4 months) Directly Observed Treatment (DOT) given 7 days a week RHZ E 400 RH (60,30) (60,30,150) ½ tab Use Ethionamide in ½ tab tab children <4kg 1 tab ½ tabs ¼ tab 1 ½ tabs if weight kg tabs ½ tab 2 tabs If weight kg ½ tabs ¾ tab 2 ½ tabs tabs 1 tab 3 tabs tabs 1 tab 4 tabs tabs 1 ½ tabs 5 tabs
43 WHO: TBM AND MILIARY TB Miliary TB cases have 60 70% chance of having meningeal involvement Use drugs with good blood-brain-barrier penetration 2HRZE 4HR (or 10HR with TBM) OR 6HRZEth (high dose therapy)
44 ETHAMBUTOL IN CHILDREN
45 CORTICOSTEROIDS In management of complicated forms of TB TBM Adenopathy compressing airways Pericarditis Prednisone 2mg/kg/day (maximum 60mg per day) or dexamethasone May need higher doses in TBM as rifampicin will decrease corticosteroid drug levels Steroids for 4 weeks, tapering to stop over 2 weeks
46 PYRIDOXINE (VITAMIN B6) INH causes peripheral neuropathy by interfering with pyridoxine metabolism Recommend daily pyridoxine supplementation in children on TB treatment if: Adolescent Breastfeeding infant HIV on HAART Malnourished
47 DEVELOPMENT PIPELINE FOR NEW DRUGS
48 TB TREATMENT: PRACTICAL CONSIDERATIONS Every case has to be notified No other way to monitor epidemic Treatment access through clinics No directly observed treatment if accessed through hospitals or private sector Non-standard regimens, with associated risk of drugresistance e.g. India, USSR Seek expert input early Best outcomes with 1 st treatment efforts!!
49 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
50 HIV CO-INFECTED CHILDREN 40 60% of childhood TB patients are HIV co-infected Most HIV-infected children respond well to a 6 month course of therapy HIV-TB co-infected children should be evaluated for ART If child not already on ART and diagnosis of TB has been made, initiation of TB therapy is the priority
51 HIV CO-INFECTED CHILDREN ABC, D4T, 3TC, FTC, AZT, ddi NVP EFV No significant interactions High risk of hepatotoxicity and sub-therapeutic levels Preferably avoid Reduced levels, but little clinical significance PIs Never unboosted PI Not double-dose (600mg/m 2 ) LPV/r unless adult 1:1 ratio of LPV/r
52 FOLLOW-UP 2 weeks after initiation of therapy At end of Intensive Phase Follow-up smear for AFB if patient was smear positive at start of treatment Every 2 months until treatment completion Symptom assessment Assess adherence Assess for adverse events Weight measurement Adjust doses to accommodate weight gain
53 CONTACT TRACING WHO recommends that for all TB patients Screen household contacts Offer INH preventive therapy to children < 5 years Risk of infection greatest when contact is close and prolonged Risk of progression to TB disease greater in children < 5 years Most progression to disease occurs in first 2 years after infection
54 IPT After exclusion of TB disease, INH prophylaxis should be given to: All children under 5 years of age and HIV-infected children (irrespective of age) in contact with an infectious case of TB (drug susceptible TB and MDR- TB) All children under 5 years of age with a positive Mantoux (10 mm in diameter or greater) All HIV-infected children, irrespective of their age, with a positive Mantoux (5 mm in diameter or greater) SA National TB Guidelines 2009
55 OVERVIEW Burden of disease & epidemiology Pathogenesis (not covered) Clinical presentation of childhood TB Diagnosis of paediatric TB Categorizing TB infections in children Anti-tuberculous therapy in children Miscellaneous issues BCG
56 BCG Live, attenuated strain of M bovis Only licensed TB vaccine Developed 1908, first administered 1921 Number of related strains In SA: Danish Efficacy: 0-80%, probably ± 50% Protects children against severe TB? Decreases non-tb morbidity & mortality
57 BCG Protects against leprosy? Role of intestinal helminths & environmental mycobacteria in reducing protection Local complications Disseminated BCG Contra-indicated in HIV-infected individuals Urgent need for better vaccine in various stages of testing
58
Diagnosis of tuberculosis in children
Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence
More informationTB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012
TB & HIV CO-INFECTION IN CHILDREN Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children
More informationDiagnosis of tuberculosis in children H Simon Schaaf
Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence
More informationTB in Children. Rene De Gama Block 10 Lectures 2012
TB in Children Rene De Gama Block 10 Lectures 2012 Contents Epidemiology Transmission and pathogenesis Diagnosis of TB TB and HIV Management Epidemiology The year 2000 8.3 million new TB cases diagnosed
More informationTB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011
TB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011 OUTLINE Background Global Incidence The Problem" The 3 I s Drug Resistant
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationTB: A Supplement to GP CLINICS
TB: A Supplement to GP CLINICS Chapter 10: Childhood Tuberculosis: Q&A For Primary Care Physicians Author: Madhukar Pai, MD, PhD Author and Series Editor What is Childhood TB and who is at risk? India
More informationHIV prevalance in TB cases
TUBERCULOSIS HIV prevalance in TB cases Top 5 AIDS indicative diseases; EUR, 2003 58% 35% 25% 11% 7% TB HIV wasting s. Candidiasis Rec. pneumonia HIV encephal. 26% 25% 31% 31% 16% 8% 7% 16% 14% 10% TB
More informationDiagnosis and Medical Management of Latent TB Infection
Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,
More informationDiagnosis and Treatment of Tuberculosis, 2011
Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is
More informationThe SAARC Regional Programme Guidelines of Diagnosis & Management of Pediatric Tuberculosis (TB) 2017
The SAARC Regional Programme Guidelines of Diagnosis & Management of Pediatric Tuberculosis (TB) 2017 SAARC Tuberculosis and HIV/AIDS Centre (STAC) Thimi, Bhaktapur P.O.Box No.: 9517, Kathmandu, Nepal.
More informationDr Francis Ogaro MTRH ELDORET
Dr Francis Ogaro MTRH ELDORET TB in children often severe, disseminated and can progress rapidly and with poor outcome TB diagnosis in children has relied on clinical, imaging, microscopy and TST findings.
More informationEuropean Respiratory Society Congress Barcelona President Award. Dr Walther Guerrero Ciquero
TUBERCULOSIS Homework European Respiratory Society Congress Barcelona 2010 President Award Dr Walther Guerrero Ciquero ERS will continue to honour his memory through a Fellowship bearing his name. Stop
More informationPediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017
Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationPediatric TB Lisa Armitige, MD, PhD September 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.
More informationStandard Operating procedures for Gastric lavage/aspiration; Mantoux and Sputum induction (Adapted from the Childhood TB
Standard Operating procedures for Gastric lavage/aspiration; Mantoux and Sputum induction (Adapted from the Childhood TB Desk Guide revised 2018) How to perform a Paediatric Gastric Aspiration Materials
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationCase Management of the TB/HIV Infected Patient
TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Case Management of the TB/HIV Infected Patient Sarah Hoffman, MPH, MSN, ACRN December 9, 2009 TB/HIV: Considerations in the Care of the Coinfected
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More informationTuberculosis Intensive
Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationTuberculosis. Objectives. Tuberculosis in children is usually spead from an adult with untreated pulmonary tuberculosis.
8 Tuberculosis Objectives When you have completed this unit you should be able to: Give reasons why tuberculosis is an important and dangerous disease. Describe primary tuberculous infection of the lung.
More informationTB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009
TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages
More informationPEDIATRIC TUBERCULOSIS. Objectives. Children are not just small adults. Pediatric Tuberculosis 1
PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationPEDIATRIC TUBERCULOSIS
PEDIATRIC TUBERCULOSIS Ann M. Loeffler, M.D. Faculty Consultant Curry International Tuberculosis Center Objectives At the end of this session, participants will be able to describe: how pediatric patients
More informationDESK GUIDE FOR DIAGNOSIS AND MANAGEMENT OF TB IN CHILDREN
DESK GUIDE FOR DIAGNOSIS AND MANAGEMENT OF TB IN CHILDREN Second edition, 2015 International Union Against Tuberculosis and Lung Disease (The Union) 68 Boulevard Saint-Michel, 75006 Paris, France Second
More informationTUBERCULOSIS. By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi
TUBERCULOSIS By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi Tuberculosis Infectious, Systemic, Chronic granulomatous disease caused by mycobacterium tuberculosis DEFINITION
More informationTB Intensive San Antonio, Texas
TB Intensive San Antonio, Texas August 2-5, 2011 Pediatric TB Jeffrey Starke, MD August 5, 2011 Jeffrey Starke, MD has the following disclosures to make: Is on a data safety monitoring board for Hoffman
More informationContent. Foreword...3 Acknowledgements...4 I. Introduction...6 Epidemiology...7
Content Page Foreword...3 Acknowledgements...4 I. Introduction...6 II. Epidemiology...7 1. Mode of transmission in children...7 2. Public health importance...7 3. Risk of infection...7 4. Risk of developing
More informationTargeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease
Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will
More informationThe Origin of Swine Flu
How the Heck Do You Diagnose Tuberculosis in Children, Anyway? Jeffrey R. Starke, M.D. Professor and Vice Chairman of Pediatrics Baylor College of Medicine Houston, Texas USA The Origin of Swine Flu MAIN
More informationRecognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016
Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the
More informationAlgorithmic Approaches to Child TB Management in Resource-limited Settings
Algorithmic Approaches to Child TB Management in Resource-limited Settings Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital
More informationTuberculosis and BCG
Tuberculosis and BCG Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital Melbourne Child Lung Health International Union Against
More informationDIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE
DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case
More informationNorthwestern Polytechnic University
Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions
More informationTB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012
TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests
More informationTB in Children. The diagnostic challenge. Ralph Diedericks Red Cross Hospital
TB in Children The diagnostic challenge Ralph Diedericks Red Cross Hospital TB in children Brief epidemiology Clinical issues in primary TB Cases Rates of TB infection 2005 TST survey reported a TB prevalence
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationContact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan
Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan 17 th Annual Conference, The Union-North American Region, Vancouver, Canada. 28 February 2013 Farhana Amanullah Director
More informationGUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN 2013 health Department: Health REPUBLIC OF SOUTH AFRICA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN 2013 Published by the Department
More informationTuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH)
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 20 Tuberculosis Learning Objectives 1. Describe the biologic characteristics of the agent 2. Determine the epidemiologic characteristics
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed
More informationEtiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition
Pulmonary Tuberculosis Debra Mercer BSN, RN, RRT Definition Tuberculosis is a contagious bacterial infection of the lungs caused by Mycobacterium Tuberculosis (TB) Etiological Agent: Mycobacterium Tuberculosis
More informationEpidemiology and diagnosis of MDR-TB in children H Simon Schaaf
Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions
More informationANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM
ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM The form and content of the explanatory note is to: Inform those responsible for completing the DMR 164 Reporting Form - as to
More informationTOG The Way Forward
TOG 2016- The Way Forward Main Changes in Diagnostic algorithm Definition (Type, Classification, Outcome) Registration at the time of Diagnosis (PHI level Notification Register) Long term follow up (till
More informationTUBERCULOSIS. Pathogenesis and Transmission
TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are
More informationPediatric Drug-Resistant TB in China
Pediatric Drug-Resistant TB in China Shuihua Lu,Tao Li Shanghai Public Health Clinical Center Jan.18,2013 A MDR-TB CASE A four and a half years old boy, spent 4 yeas of his life in hospital. His childhood
More information11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction
SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,
More informationTB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)
TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationResearch in Tuberculosis: Translation into Practice
Case History Research in Tuberculosis: Translation into Practice This is a 6-year6 year-old Bosnian male, who presented to ER with one-week history of fever and occasional vomiting. No cough, difficulty
More informationDiagnosis of TB in Children. Dr Jacquie Narotso Oliwa
Diagnosis of TB in Children Dr Jacquie Narotso Oliwa 1 Objectives To identify the common clinical presentations of TB in children Overview of diagnostic measures To understand a simplified approach to
More information10. TB and HIV Infection
10. TB and HIV Infection The management of patients with TB and HIV infection is complex, requiring management by a multidisciplinary team which includes physicians with expertise in the treatment of both
More informationTB Intensive San Antonio, Texas August 7-10, 2012
TB Intensive San Antonio, Texas August 7-10, 2012 An Introduction to Childhood Tuberculosis Kim Smith, MD, MPH August 10, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests
More informationTuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012
Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally
More informationNew Tuberculosis Guidelines. Jason Stout, MD, MHS
New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults
More informationPREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal
PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.
More informationTUBERCULOSIS. Presented By: Public Health Madison & Dane County
TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationManagement of Pediatric Tuberculosis in New Jersey
Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis
More informationTB Nurse Case Management
TB Nurse Case Management San Antonio, Texas March 2-4, 2011 Pediatric TB Andrea T. Cruz, MD, MPH March 2, 2011 Andrea Cruz, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationNew Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents
New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea
More informationErrors in Dx and Rx of TB
Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a
More informationCDC Immigration Requirements: Tuberculosis Screening for Children
CDC Immigration Requirements: Tuberculosis Screening for Children Ann M. Loeffler, M.D. Curry International TB Center San Francisco, CA March, 2013 Atlanta, Georgia CDC Immigration Requirements: Tuberculosis
More informationDiagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015
Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationSelf-Study Modules on Tuberculosis
Self-Study Modules on Tuberculosis Targe te d Te s ting and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control
More informationCHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]
CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] QUESTION: : Which children in the United States should get a tuberculin skin test? Do questionnaires really work? Jeffrey
More informationChapter 4 Diagnosis of Tuberculosis Disease
Chapter 4 Diagnosis of Tuberculosis Disease Table of Contents Chapter Objectives.... 75 Introduction.... 77 Medical Evaluation.......................................................... 78 Chapter Summary...
More informationTHE UNION S DESK GUIDE FOR DIAGNOSIS AND MANAGEMENT OF TB IN CHILDREN
THE UNION S DESK GUIDE FOR DIAGNOSIS AND MANAGEMENT OF TB IN CHILDREN THIRD EDITION 2016 3 The Union s desk guide for diagnosis and management of TB in children Third edition 2016 International Union
More informationDiagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:
More informationTuberculosis Elimination: The Role of the Infection Preventionist
Tuberculosis Elimination: The Role of the Infection Preventionist Preface: What Happens when Health Care Professionals are not familiar with TB? A 15 year old student was diagnosed with highly infectious
More informationNew Standards for an Old Disease:
New Standards for an Old Disease: Practical Implications of the TB Standards TB Prevention and Control Saskatchewan September 16, 2015 Practical Implications of the TB Standards Learning Objectives At
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationTB in the Correctional Setting Florence, Arizona October 7, 2014
TB in the Correctional Setting Florence, Arizona October 7, 2014 Diagnosis and Treatment of TB Disease Renuka Khurana, MBBS, MPH October 7, 2014 Renuka Khurana, MSSB, MPH has the following disclosures
More informationWhat Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390
386 Chapter 25 In this chapter: What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390 Preventing TB 391 Working for Change 391 387 (TB)
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening
More informationResearch Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012
Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How
More informationIn our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between
In our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between the two, we also propose a classification system for
More informationTB the basics. (Dr) Margaret (DHA) and John (INZ)
TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2
More informationTB Intensive Tyler, Texas December 2-4, 2008
TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)
More informationTuberculosis: A Provider s Guide to
Tuberculosis: A Provider s Guide to Diagnosis and Treatment of Active Tuberculosis (TB) Disease and Screening and Treatment of Latent Tuberculosis Infection (LTBI) Alameda County Health Care Services Agency
More informationTB Clinical Guidelines: Revision Highlights March 2014
TB Clinical Guidelines: Revision Highlights March 2014 AIR TRAVEL & TB CONTROL With respect to non-ambulance air travel of patients diagnosed with or suspected as having active Mycobacterium tuberculosis,
More informationWESTERN CAPE ART GUIDELINES PRESENTATION 2013
WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active
More informationCHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 TUBERCULOSIS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY GLOBAL EMERGENCY: * Tuberculosis kills 5,000 people a day! * 2.3 million die each year!
More informationPediatric tuberculosis (i.e., Tuberculosis
G U I D E L I N E S Updated National Guidelines for Pediatric Tuberculosis in India, 2012 ASHOK KUMAR, DEVESH GUPTA, SHARATH BURUGINA NAGARAJA, *VARINDER SINGH, # GR SETHI AND JAGADISH PRASAD From Central
More informationTB in the Patient with HIV
TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to
More informationTuberculosis (TB) Fundamentals for School Nurses
Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of
More informationLet s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Abstract Nearly 50% of patients with
More informationTB Intensive San Antonio, Texas May 7-10, 2013
TB Intensive San Antonio, Texas May 7-10, 2013 TB in the HIV Patient Lisa Armitige, MD, PhD May 09, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests No relevant
More informationMycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE
Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting
More informationCDC IMMIGRATION REQUIREMENTS:
CDC IMMIGRATION REQUIREMENTS: Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy October 1, 2009 Table of Contents Preface...i Tuberculosis Screening...1
More informationImmune Reconstitution Inflammatory Syndrome. Dr. Lesego Mawela
Immune Reconstitution Inflammatory Syndrome Dr. Lesego Mawela TOPICS FOR DISCUSSION IRIS Case Epidermiology Pathogenesis of IRIS Risk factors for IRIS Epidemiology of IRIS Health system burden of IRIS
More informationThe Diagnosis of Active TB. Deborah McMahan, MD TB Intensive September 28, 2017
The Diagnosis of Active TB Deborah McMahan, MD TB Intensive September 28, 2017 Agenda Epidemiology Big picture Conditions that Should Make You Suspicious Which test? Eeenie meenie miny mo Radiographic
More informationMaking the Diagnosis of Tuberculosis
Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes
More information